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We present the complete cDNA and derived amino acid sequence of the non-collagenous domain NC1 of 
a2(IV). Comparison with the corresponding NC1 domain of a,(IV) reveals a high degree of homology at 
the protein level, in contrast to the barely homologous triple-helical sequences of both chains. 
Basement membrane Collagen IV 
1. INTRODUCTION 
The main collagenous component of basement 
membranes is collagen IV. A molecule of collagen 
IV consists of two LYI- and one cuz-chain with about 
1650 amino acid residues. Self-assembly of the 
molecules in the extracellular matrix occurs via like 
ends, e.g. four molecules overlap at the N-terminal 
triple helix (7 S domain) whereas two type IV 
monomers become connected via the C-terminal 
globular domain NCl. The network thus formed is 
stabilized by intermolecular disulfide bonds and 
non-reducible covalent crosslinks [ 11. 
The primary structure of collagen IV is under in- 
vestigation at the protein and cDNA level. For the 
aI(chain, the N-terminal 7 S domain of human 
[2], the C-terminal NC1 domain of mouse and 
human and an adjacent portion of the triple helix 
[3-51 as well as 914 residues of the main triple- 
helical region of human [6] have been published. 
Some parts of this region are also known from 
murine and bovine [7,8] collagen IV. Of the 
cuz(IV)-chain, only the 5 1 l-residue-long C-terminal 
portion of the triple helix has been reported [9]. 
Here we present he primary structure of the adja- 
cent non-collagenous globular domain NC1 of the 
auz(IV)-chain as derived from cDNA sequence. 
* To whom reprint requests should be addressed 
NC1 domain Sequence homology 
2. MATERIALS AND METHODS 
2.1. Construction of the cDNA library and 
screening for aa(specific clones 
The cDNA library cI1 was constructed with 
sucrose-gradient-purified RNA from PYS-2 cells 
[lo] and the vector pUC931, using a simplified ver- 
sion of the procedure of Okayama and Berg [l 11. 
pUC931 is a derivative of pUC9 [12] in which the 
polylinker of Ml3 tg13 1 [ 131 has been inserted. 
Details of the construction of this vector and the 
library cI1 will be published elsewhere [24]. Part of 
this library was screened with the nick-translated 
3’ EcoRI/PstI fragment of the a2(IV) clone pAIIa. 
The clone pAIIa and the conditions for hybridiza- 
tion have been described by Schwarz et al. [9]. 
Screening of library cII identified clone pAIIc. 
2.2. Subcloning and sequencing 
Plasmid DNA of the clones was obtained by the 
method of Birnboim and Doly [14]. Relevant 
restriction fragments of clones pAIIa and pAIIc 
were subcloned into Ml3 tg130 and/or tg131 
(Amersham) and sequenced by the chain termina- 
tion method of Sanger et al. [15]. Each fragment 
was sequenced at least once on both strands. 
2.3. Computer analysis of sequences 
The computer program ALIGN [16] was used 
with the mutation data matrix, a penalty for a 
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break of 12 and 100 random runs. The alignment 
score (in SD units) is the number of standard 
deviations by which the maximum score for the 
real sequences exceeds the average maximum score 
for random permutations of the sequences. 
The program BESTFIT [17] produces an op- 
timal alignment of sequences by scoring + 1.0 for 
identical symbols, - 0.9 for mismatches and addi- 
tional negative values for introduced gaps. For the 
value ratio, the score is divided by the length (base 
pairs) of the shorter sequence. Thus the ratio is 
smaller than 1 .O for any two sequences that are not 
identical. 
3. RESULTS 
3.1. Characterization of the clones 
We have isolated two overlapping cDNA clones, 
pAIIa and pAIIc, which together contain the se- 
quence for the entire NC1 domain of the LYZ(IV)- 
chain of mouse. Clone pAIIa has been isolated 
previously [9] and comprises about 560 bp coding 
for the NC1 domain, in addition to 1290 bp coding 
for the triple helix. Clone pAIIc starts at position 
99 of the NC1 sequence, overlaps about 460 bp 
with the 3 ‘-end of clone pAIIa and also includes 
the missing 3’ 130 bp of the NC1 domain and an 
additional 950 bp of the 3 ‘-untranslated region. 
The restriction map of the two clones and the cor- 
responding subclones in Ml3 are shown in fig. 1, 
together with the sequencing strategy. 
3.2. Characterization of the ~uz(IV) NC1 domain 
at the protein level 
In fig.2, we present the complete cDNA and 
derived protein sequence of the cyz(IV) NC1 do- 
main of mouse. The corresponding sequence for 
the al(IV)-chain of mouse and human has been 
published recently [3-51. This allows for the first 
time a comparison of both chains in this important 
crosslinking domain. The LYZ(IV) NC1 domain con- 
sists of 228 amino acid residues and is thus one 
residue shorter than the (YI(IV) sequence. Align- 
ment of both protein sequences revealed an ex- 
cellent homology (fig.2). Both domains contain 12 
cysteine residues which occur at identical positions 
in a highly conserved surrounding, if two gaps in 
az(IV) (positions 92, 94) and one gap in awl 
(position 176) are introduced. An alignment of the 
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Fig.1. Restriction map and sequencing strategy of the 
cuz(IV)-specific cDNA clones pAIIa and pAIIc. The 
position of the two clones with respect o the LYE 
domains is given at the top. Segments ma and mc refer 
to subclones of pAIIa and pAIIc in the vectors Ml3 
tg130 and/or tg131. Arrows indicate the direction of 
multiple sequencing. The restriction sites in brackets are 
contributed by the vectors. 
DNA sequence with the program BESTFIT 
(UWGCG, [17]) suggested some additional gaps 
after residue 197 which have been included in fig.2. 
148 residues of both chains (65%) are identical; in 
38 additional positions (16%), conservative amino 
acid substitutions have taken place, denoted by 
italic letters. Values for the homology at the pro- 
tein and DNA levels are given in table 1. 
Because of the overall homology of the NC1 do- 
mains of both chains, it could already be an- 
ticipated that the az(IV) NC1 domain exhibits a 
similar internal homology to that found for the 
cul(IV)-chain [3-51. The first and second halves can 
be aligned in such a way that all cysteine residues 
coincide and the neighbouring amino acid residues 
are identical or similar (program ALIGN [16]). 
The values for the internal homology of both 
chains are also given in table 1. This value is 
somewhat lower for the CzYz-chain asmore gaps are 
necessary for the alignment (not shown). 
3.3. Comparison at the DNA level 
Homology of two proteins at the protein level 
does not necessarily imply a high degree of 
homology at the DNA level. Comparison of the 
DNA sequences of cul(IV) and crz(IV) NC1 reveals 
many short stretches of 5-10 identical bases (cf. 
fig.2) interrupted by stretches where at least every 
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Fig.2. Comparison of cDNA and amino acid sequence of c4IV) NC1 of mouse with the corresponding sequences from 
the cri(IV)-chain. The first row shows the protein sequence of cuz(IV) NC1 with its cDNA sequence in the second line. 
The third line gives those bases of the matched LYI cDNA sequence which differ. The fourth row contains the derived 
amino acids that are not conserved. Bold letters indicate identical amino acids, italic letters conservative substitutions. 
Bases printed in lower-case letters are complementary to the sequences above. The first amino acid residue (Ser) of the 
cuz(IV) NC1 domain had been included in the triple helix previously [9]. 
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Table 1 4. DISCUSSION 
Homology between LYI and (YZ(IV) 
Chains Domain Value 
Protein level 
~~z(IV)-U~(IV) (mouse) NCla 64.9% 
W(W) (mouse)-cyr(IV) (human) NCla 65.4% 
(or (mouse)-cyr(IV) (human) NCl= 96.9% 
al(I)-(YZ(I) (chick)b CPPa 61.2% 
cur(IV) (mouse) internal repeat NCIC 18.1 SD 
(YZ(IV) (mouse) internal repeat NCIC 16.1 SD 
DNA level 
~2(1V)_(yr(IV) (mouse) NCld 0.287 
cuz(IV) (mouse)-cYr(IV) (human)e NCld 0.293 
(or (mouse)-cur(IV) (human)e NCld 0.761 
LY~(IV)-&IV) (mouse)’ TRd 0.09 
W(W) (mouse)-cur(IV) (human)egf TRd 0.647 
a % of identical residues per number of residues of 
shorter chain 
b Sequences taken from [18] 
’ Program ALIGN 
d Program BESTFIT (ratio), gap weight 5, gap weight 
length 0.3 
e Sequences taken from [4,5] 
f Sequences taken from [3,9] 
CPP, carboxypropeptide; TR, triple helix 
Mouse muI and cyz(IV) sequences are 
moderately conserved in the entire NC1 domain, 
the most highly conserved regions comprising the 
12 cysteine residues. This homology is confined to 
the NC1 domain, since the main triple helices of 
both chains are not homologous except for the 
tripeptide repeats and the position of most of the 
triple-helical interruptions [9]. On the other hand, 
the sequences of ar(IV) of mouse and human are 
highly conserved throughout the al-chain as far as 
both sequences are known. Only seven amino acid 
residues out of 229 differ between the cur(IV) NC1 
domain of mouse and human (cf. [3-51). Of the 
222 identical residues, 148 (67%) have also iden- 
tical codons. Hence, the high degree of homology 
at the protein level is reflected at the DNA level as 
well. Many of the matching DNA strings have a 
length of 17 or 20 bp, two being even 28 and 32 bp 
long (cf. table 1). Thus, mouse cDNA clones have 
been used successfully to isolate corresponding 
human cDNA clones (cf. [4,5]). The DNA se- 
quences of both mouse and human (YI(IV) NC1 do- 
main are, to a similar extent, homologous to the 
corresponding mouse a2(IV) sequence (cf. table 1). 
This may suggest hat the aI- and az-chains started 
to diverge before the separation of the genome of 
mouse and man. 
third base is different. There are only two longer 
strings of matches (14 and 24 bases) at positions 
169-182 and 660-684. These data suggest that 
under moderately stringent conditions no 
crosshybridization between both chains will occur 
with DNA probes from this area. This conclusion 
holds all the more for the triple-helical domain (cf. 
table 1 [9]). 
Of the 148 identical amino acids, 72 (48.6%) are 
coded for by identical codons while 65 (44.2%) 
have one base exchanged. The remaining 11 
codons with two or three base exchanges code for 
leucine, arginine and serine. There are 17 serine 
residues conserved in both chains, 7 having iden- 
tical codons, and 4 with just one base exchanged. 
Surprisingly, the remaining 6 serine codons have 2 
or all bases converted to their complement. Such 
complementary base exchanges which also occur at 
other positions, have been designated with lower- 
case letters in fig.2. 
The homology between the two NC1 domains of 
the different cY(IV)-chains is nevertheless quite pro- 
nounced and similar to that found for the carbox- 
ypropeptides of collagen I [18]. We assume that 
there has been strong evolutionary pressure to con- 
serve the structure of the NC1 domains as impor- 
tant aggregation and crosslinking sites for the type 
IV collagen network, while the flexibility of the 
network tolerated a much faster divergence of the 
sequences of both chains in the triple-helical do- 
main, in contrast to the restrictions on divergence 
for the fibrillar collagen I [19]. The variations in 
structure of the NC1 domain of ar(IV) and LYZ(IV) 
may even be necessary for the correct selection of 
two al- and one az-chain to form a triple-helical 
molecule, as the NC1 domains are also believed to 
be involved in the correct alignment of the three 
chains before triple helix formation, in analogy to 
the C-terminal propeptides of collagen I [20]. 
While the carboxypropeptides of the interstitial 
collagens are cleaved off after triple helix forma- 
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tion, the NC1 domains are retained to serve as a 
crosslinking region for network formation. It has 
been a long-standing question whether at least 
some processing occurs at the C-terminal ends of 
the NC1 domains. Comparison of the C-terminal 
peptide sequences of both chains [21] with the 
cDNA sequences presented here and in [3-51 clear- 
ly shows that no processing takes place as the 
cDNA-derived protein sequences are identical to 
those of the native protein. The higher molecular 
mass for the two NC1 domains which has been 
observed intracellularly [22] may be due to in- 
completely folded and disulfide-linked NC1 
domains. 
Neither NC1 domain contains a carbohydrate 
attachment site Asn-X-Ser/Thr which is present in 
the carboxypeptides of the interstitial collagens. 
Therefore, they can contain only O-linked sugars. 
Thus, the glucosamine found earlier in prepara- 
tions of murine NC1 (less than one residue per 
chain) [23] must result from a contamination. 
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